ANGIOCOMB Antiangiogenic Therapy for Pediatric Patients With Diffuse Brain Stem and Thalamic Tumors
Status:
Completed
Trial end date:
2013-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether initial local irradiation with topotecan
and following oral antiangiogenic drugs, thalidomide, celecoxib and etoposide are effective
in the treatment of pediatric diffuse brainstem tumor.
Phase:
Phase 2
Details
Lead Sponsor:
Helsinki University Central Hospital
Collaborators:
Kuopio University Hospital Oulu University Hospital Tampere University Hospital Turku University Hospital